47P Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01

Michele Droz Dit Busset, Walid L. Shaib, Kabir Mody, Nicola Personeni, Nevena Damjanov, William Proctor Harris, Francesca Bergamo, Giovanni Brandi, Gianluca Masi, T.R. Halfdanarson, Vincent C. Tam, Laura W. Goff, Jennifer J. Knox, Antoine Hollebecque, T. Macarulla Mercadé, F. Cantero, Mikael Saulay, Stephan Braun, Milind Javle, Mitesh J. Borad